NCT04731844View on ClinicalTrials.gov

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 14, 2021

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Prostate CancerMultiple MyelomaSmoldering Multiple Myeloma (SMM)Monoclonal Gammopathy of Undetermined Significance
Interventions
DRUG

Curcumin plus Piperine

Curcumin with piperine is a well-tolerated over-the-counter supplement.

Trial Locations (1)

14623

RECRUITING

University of Rochester, Rochester

All Listed Sponsors
lead

University of Rochester

OTHER